Primary |
Drug Use For Unknown Indication |
43.9% |
Hypertension |
24.2% |
Product Used For Unknown Indication |
10.6% |
Myocardial Ischaemia |
7.6% |
Diabetes Mellitus |
3.0% |
Heart Transplant |
3.0% |
Liver Transplant |
3.0% |
Heart Valve Replacement |
1.5% |
Infection |
1.5% |
Upper Respiratory Tract Infection |
1.5% |
|
Oedema Peripheral |
9.1% |
Thrombocytopenia |
9.1% |
Vomiting |
9.1% |
Weight Decreased |
9.1% |
Bedridden |
4.5% |
Death |
4.5% |
Dermatitis Allergic |
4.5% |
Hepatic Steatosis |
4.5% |
Hydrocele |
4.5% |
Nausea |
4.5% |
Nuclear Magnetic Resonance Imaging Abnormal |
4.5% |
Poisoning |
4.5% |
Post Procedural Complication |
4.5% |
Pulmonary Fibrosis |
4.5% |
Renal Cell Carcinoma Stage Unspecified |
4.5% |
Suicidal Ideation |
4.5% |
Systemic Lupus Erythematosus |
4.5% |
Tooth Disorder |
4.5% |
|
Secondary |
Hypertension |
28.4% |
Product Used For Unknown Indication |
20.6% |
Drug Use For Unknown Indication |
6.4% |
Drug Exposure During Pregnancy |
5.9% |
Cardiac Disorder |
4.4% |
Osteoporosis |
4.4% |
Cardiovascular Disorder |
3.9% |
Myocardial Infarction |
3.9% |
Depression |
2.9% |
Essential Hypertension |
2.9% |
Renal Transplant |
2.5% |
Abdominal Pain |
2.0% |
Constipation |
2.0% |
Pain |
2.0% |
Reflux Oesophagitis |
2.0% |
Arrhythmia |
1.5% |
Hypothyroidism |
1.5% |
Anxiety |
1.0% |
Arteriosclerosis |
1.0% |
Blood Cortisol Increased |
1.0% |
|
Small Bowel Angioedema |
20.0% |
Completed Suicide |
8.0% |
Flushing |
8.0% |
Agranulocytosis |
6.0% |
Presyncope |
6.0% |
Pruritus |
6.0% |
Staphylococcal Infection |
6.0% |
Faecal Incontinence |
4.0% |
Hepatic Steatosis |
4.0% |
Premature Baby |
4.0% |
Scotoma |
4.0% |
Suicidal Ideation |
4.0% |
Toothache |
4.0% |
Treatment Noncompliance |
4.0% |
Death |
2.0% |
Dermatitis Bullous |
2.0% |
Dizziness |
2.0% |
Dyspnoea Exertional |
2.0% |
Gingival Pain |
2.0% |
Haemoglobin Decreased |
2.0% |
|
Concomitant |
Product Used For Unknown Indication |
31.1% |
Hypertension |
18.9% |
Drug Use For Unknown Indication |
12.8% |
Back Pain |
4.1% |
Diabetes Mellitus |
3.4% |
Rheumatoid Arthritis |
3.3% |
Renal Transplant |
2.8% |
Depression |
2.6% |
Prophylaxis |
2.6% |
Nausea |
2.3% |
Type 2 Diabetes Mellitus |
2.3% |
Non-small Cell Lung Cancer |
2.0% |
Non-small Cell Lung Cancer Metastatic |
2.0% |
Hepatic Neoplasm Malignant |
1.8% |
Blood Cholesterol Increased |
1.6% |
Transplant |
1.5% |
Anxiety |
1.3% |
Cystitis |
1.3% |
Multiple Myeloma |
1.3% |
Nutritional Support |
1.3% |
|
Hepatic Encephalopathy |
7.2% |
Nausea |
7.2% |
Thrombocytopenia |
7.2% |
Vasculitis |
7.2% |
Weight Increased |
7.2% |
Drug Interaction |
5.8% |
Pain In Extremity |
5.8% |
Renal Failure |
5.8% |
Rheumatoid Arthritis |
5.8% |
Hypertension |
4.3% |
Hypotension |
4.3% |
Lethargy |
4.3% |
Mutism |
4.3% |
Vomiting |
4.3% |
White Blood Cell Count Increased |
4.3% |
Anaemia |
2.9% |
Depression |
2.9% |
Drug Ineffective |
2.9% |
General Physical Health Deterioration |
2.9% |
Interstitial Lung Disease |
2.9% |
|